Intraperitoneal Administration of Dual Immune Checkpoint Inhibitor Therapy in Recurrent Gynecologic Malignancies: Updated Results of a Phase 1b Study
GYNECOLOGIC ONCOLOGY(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined